Detalles de la búsqueda
1.
Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies.
J Asthma
; 60(2): 403-411, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348408
2.
Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
Pulm Pharmacol Ther
; 70: 102019, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33771722
3.
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
Pulm Pharmacol Ther
; 62: 101919, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387408
4.
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
J Asthma Allergy
; 16: 123-134, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714049
5.
Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
Respir Med
; 211: 107172, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906187
6.
Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.
Respirology
; 17(2): 379-89, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22122202
7.
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
Adv Ther
; 39(6): 2365-2378, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072888
8.
Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies.
Clin Drug Investig
; 31(4): 247-55, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21184620
9.
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.
BMJ Open Respir Res
; 8(1)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737310
10.
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies.
BMJ Open Respir Res
; 8(1)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452934
11.
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
Respir Med
; 180: 106311, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33711782
12.
Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: A randomised, double-blind, placebo-controlled trial.
Allergol Int
; 59(3): 285-293, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20567133
13.
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Lancet Respir Med
; 8(10): 1000-1012, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653074
14.
24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol.
Respir Med
; 104(11): 1629-37, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20619623
Resultados
1 -
14
de 14
1
Próxima >
>>